No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Established in 1976 and headquartered in Mumbai, India, Lyka Labs Limited is a pharmaceutical firm specializing in the development, manufacturing, and marketing of a wide array of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses numerous therapeutic areas, including intensive care, gastroenterology, anti-infectives, anti-fungals, surgery, urology, wound care, anesthesia, and various dermatological and cosmeceutical applications like topical steroids, anti-acne, anti-aging, and hair care. These products are available in diverse forms, such as injections, creams, ointments, gels, and lotions. Beyond its own offerings, Lyka Labs also provides contract manufacturing services to other major pharmaceutical companies and offers comprehensive medical and technical support. This support includes manufacturing expertise, facility assistance, and crucial technical data such as molecule stability testing, impurity profiling, and bioequivalence (BA/BE) clinical study data. The company's market reach extends globally, with exports to various countries including Bangladesh, Cambodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam.
www.lykalabs.comNo one on the platform currently holds LYKALABS.NS.
No tracked institution reports a position in LYKALABS.NS as of their last filing.
No one on the platform has traded LYKALABS.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| LYKALABS.NSLyka Labs Limited | $80.11 | -1.40% | $2.9B | — |
| BAFNAPH.NSBafna Pharmaceuticals Limited | $309.00 | +0.55% | $7.3B | — |
| NECLIFE.BONectar Lifesciences Limited | $10.99 | -3.43% | $2.1B | — |
| NECLIFE.NSNectar Lifesciences Limited | $10.90 | -4.39% | $2.1B | — |
| SMSLIFE.BOHaleos Labs Limited | $1420.00 | -10.29% | $4.3B | — |
| SMSLIFE.NSSMS Lifesciences India Limited | $1299.00 | +0.81% | $3.9B | — |
| TAKE.BOTAKE Solutions Limited | $17.79 | -4.56% | $2.6B | — |
Source: Financial Modeling Prep · peers by sector/industry